Top Stories
-
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
-
As Davangere Devanand, a neurologist at CUIMC, combed through the reams of scientific data on Alzheimer’s, he stumbled across a surprising idea – could an infection be involved in driving the disease?
-
Of all the possible contributors, intense physical activity was the likely disease-modifying factor, Davangere Devanand, MD, of CUIMC, and co-authors wrote in Alzheimer's & Dementia
-
Dr. Lawrence Honig, professor of neurology at Columbia University Irving Medical Center, speaks about the new Alzheimer drug trial results
Latest News
- October 18, 2021
Dr. Manly was elected to NAM for her pioneering work improving detection of cognitive impairment among racially, culturally, and socio-economically diverse adults
- August 30, 2021
Finding out exactly which type of dementia you or your loved one has may be scary, but it’s important to identify the condition as early as possible
Topic
- July 8, 2021
There is a robust market for books that praise our seemingly feeble habits of mind.
- June 28, 2021
The federal health insurance program may limit who can get the drug, which Biogen priced at $56,000 a year, to limit the financial impact
- June 8, 2021
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
- June 7, 2021
After exercising, choose a brain-healthy recovery meal.
- June 4, 2021
Other researchers are not convinced that these biomarkers vary by race, primarily because so little Alzheimer’s research has been conducted on Black and Latinx people.
-
Source:
ForbesMay 21, 2021It is well established that people who had fewer opportunities to receive education when they were children are at higher risk for Alzheimer’s disease later in life, noted Dr. Jennifer Manly
-
Source:
CUIMC NewsroomMarch 30, 2021A new study on COVID-19 patients with dementia led by James Noble, MD, MS associate professor of neurology at CUIMC
- March 24, 2021
Inaugural Neurology Clinician of the Year Award
